Importantly, BRCA1/BRCA2/ATM mutation carriers were markedly younger in the localized PCa cohort than in the advanced PCa group from our previous study [19]: 61.20 vs. 68.30 years; p = 0.06. This evidence concerns the gene BRCA2 and posterior cortical atrophy.